Ken Ho ESA-SRB-AOTA 2019

Abstracts this author is presenting:

• A novel liver-targeted testosterone-therapy for the prevention of sarcopaenia in androgen deprived men with prostate cancer: a double-blind placebo-controlled study — ESA Clinical Orals - Testosterone and Transgender